Orthofix Medical Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Orthofix Medical Inc. (OFIX) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $7.10 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-06.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2023-03-06
- Orthofix Medical Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $7.10M, a 72.90% decline from fiscal 2021.
- Orthofix Medical Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2021 was $26.20M, a 122.03% increase from fiscal 2020.
- Orthofix Medical Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2020 was $11.80M, a 14.56% increase from fiscal 2019.
- Orthofix Medical Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2019 was $10.30M, a 281.48% increase from fiscal 2018.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | $7.10M 10-K · filed 2023-03-06 | |
| 2021-12-31 | $26.20M 10-K · filed 2022-02-25 | |
| 2020-12-31 | $11.80M 10-K · filed 2021-02-26 | |
| 2019-12-31 | $10.30M 10-K · filed 2020-02-24 | |
| 2018-12-31 | $2.70M 10-K · filed 2019-02-25 | |
| 2017-12-31 | $4.60M 10-K · filed 2018-02-26 | |
| 2016-12-31 | -$1.60M 10-K · filed 2017-02-27 | |
| 2015-12-31 | $5.90M 10-K · filed 2016-02-29 | |
| 2014-12-31 | $5.60M 10-K · filed 2015-04-29 | |
| 2013-12-31 | $5.40M 10-K/A · filed 2015-03-31 | $5.10M 10-K · filed 2014-03-31 |
| 2012-12-31 | $7.30M 10-K/A · filed 2014-03-24 | $7.00M 10-K · filed 2013-03-01 |
| 2010-12-31 | -$1.90M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |